Beryl Drugs Q4 Results

  • BSE: 524606
  • NSE: -
  • ISIN: INE415H01017
  • Sector: Biotechnology & Drugs
BSE
21.90-1.30 (-5.60%)
Volume2.94 K
Updated: Fri 12 Dec, 2025 | 15:28:46
NSE
This stock is not traded on NSE
Today: 21.05
23.00
52-Wk: 17.35
43.70

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Beryl Drugs Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 25Dec 24QoQ CompMar 24YoY Comp
    Total Operating Expense 5.045.12-1.62%3.5044.06%
    Depreciation/ Amortization 0.320.311.25%0.320.35%
    Operating Income -1.070.190.00%-0.52104.02%
    Net Income 0.150.05191.00%-0.350.00%
    Other Operating Expenses Total 1.312.36-44.36%-0.330.00%
    Net Income Before Taxes 0.100.16-36.57%-0.420.00%
    Total Revenue 3.975.31-25.16%2.9833.54%
    Selling/ General/ Admin Expenses Total 0.590.62-4.14%0.4921.68%
    Diluted Normalized EPS 0.300.10201.38%-0.680.00%

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

          ✕

          Wait for it…

          Log in to our website to save your bookmarks. It'll just take a moment.

          ✕

          Wait for it…

          Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.